Cannabinoid patch fails to deliver for Zynerba
ZYNE Stock Price Forecast. Should You Buy ZYNE?
Zynerba Pharmaceuticals is specialty pharmaceutical company, focuses on developing transdermal cannabinoid therapies Stock Photo - Alamy
Zynerba Pharmaceuticals' (ZYNE) Highest Price: $36.49 (on 08-13-2015)
Zynerba Pharmaceuticals Inc gets renewed 'Buy' rating, premium $11 price target from Canaccord Genuity after growth conference
Zynerba Pharmaceuticals Stock Forecast: down to 0.000001 USD? - ZYNE Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Zynerba Pharmaceuticals (ZYNE) - price stock, stock chart, quote online, dividends, stock analysis, stock news, company profile
Home - Zynerba
Zynerba Pharmaceuticals Stock Forecast: down to 0.000001 USD? - ZYNE Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Zynerba Pharmaceuticals Inc (ZYNE) Stock Price Last Month
Zynerba's Stock Forecast for 2021: Is ZYNE a Good Stock to Buy?
ZYNE Stock Price and Chart — NASDAQ:ZYNE — TradingView
Home - Zynerba
Is it Time to Dump Zynerba Pharmaceuticals Inc (ZYNE) Stock After it Is Down 7.02% in a Week?
Where Will Zynerba Pharmaceuticals Inc (ZYNE) Stock Go Next After It Is Lower By 0.00% in a Week?
Zynerba Stock Price Plummets 51% After CBD Drug Fails Trial
Zynerba Pharmaceuticals Stock Is a Cannabis Stock With 700%+ Upside
ZYNERBA PHARMACEUTICALS, INC. : ZYNE Stock Price | US98986X1090 | MarketScreener
Zynerba Pharmaceuticals (ZYNE) Investor Presentation - Slideshow (NASDAQ:ZYNE) | Seeking Alpha
Zynerba's Stock Forecast for 2021: Is ZYNE a Good Stock to Buy?
